Date of dispatch of this notice: 29/03/2022
Expire date: 04/05/2022
External Reference: 2022-224076
TED Reference: 2022/S 065-170250
Prior information notice
Information
Published
Prior information notice
Prior information notice
Services
Directive 2014/24/EU
This notice is for prior information only
Section I: Contracting authority
I.1)
Name and addresses
Health Service Executive (HSE)
N/A
Head Office
Naas
Millennium Park
IE
Contact person:
Enda Caulfield
E-mail:
enda.caulfield@hse.ie
NUTS code:
IE -
IRELAND
Main address:
http://www.hse.ie
Address of the buyer profile:
https://irl.eu-supply.com/ctm/Company/CompanyInformation/Index/461
I.2)
Joint procurement
The contract is awarded by a central purchasing body
I.3)
Communication
Access to the procurement documents is restricted. Further information can be obtained at:
http://irl.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=210494&B=ETENDERS_SIMPLEAdditional information can be obtained from
the abovementioned address:
I.4)
Type of the contracting authority
Body governed by public law
I.5)
Main activity
Health
Section II: Object
II.1)
Scope of the procurement
II.1.1)
Title
Diabetic RetinaScreen, the national Diabetic Retinal Screening Programme in Ireland
Reference number:
Diabetic RetinaScreen HSE 17737
II.1.2)
Main CPV code
85100000
-
Health services
II.1.3)
Type of contract
Services
II.1.4)
Short description
Diabetic RetinaScreen, the National Diabetic Retinal Screening Programme in Ireland commenced early 2013 offering free regular diabetic retinopathy screening for approx. 180,000 eligible people with diabetes aged 12 years and older. Around 180,000 participants per year are invited for regular digital screening (RDS) or Optical Coherence Tomography (OCT) screening and it is likely this will increase to in excess of 200,000 people in the coming years. Since its inception, Diabetic RetinaScreen has provided over half a million eye screening tests. The programme has referred approx. 47,000 participants to hospital for follow up or treatment. To support the delivery of Diabetic RetinaScreen, the HSE is notifying the market of its intention to procure a suitably qualified photographic and grading service to deliver retina screening. This is not a call for competition. A Contract Notice will issue in due course to commence the procurement process.
II.1.6)
Information about lots
This contract is divided into lots:
no
II.2)
Description
II.2.2)
Additional CPV code(s)
85100000
-
Health services
85160000
-
Optician services
85121200
-
Medical specialist services
85140000
-
Miscellaneous health services
II.2.3)
Place of performance
NUTS code:
IE -
IRELAND
II.2.4)
Description of the procurement
Diabetic RetinaScreen, the National Diabetic Retinal Screening Programme in Ireland commenced early 2013. The programme offers free regular diabetic retinopathy screening for approximately 180,000 eligible people with diabetes aged 12 years and older.
The aim of the national programme is to reduce morbidity in the population through early detection of retinopathy. Early detection and treatment of retinopathy greatly improves health outcomes. The programme invites around 180,000 participants per year for regular digital screening (RDS) or Optical Coherence Tomography (OCT) screening, it is likely this will increase to in excess of 200,000 people in the coming years. Since its inception, Diabetic RetinaScreen has provided over half a million eye screening tests. The programme has referred approx. 47,000 participants to hospital for follow up or treatment.
To support the delivery of the Diabetic RetinaScreen programme, the HSE wishes to notify the market of its intention to procure a suitably qualified photographic and grading service to deliver retina screening. This is not a call for competition. A Contract Notice will issue in due course to commence the procurement process.
The aim of the national programme is to reduce morbidity in the population through early detection of retinopathy. Early detection and treatment of retinopathy greatly improves health outcomes. The programme invites around 180,000 participants per year for regular digital screening (RDS) or Optical Coherence Tomography (OCT) screening, it is likely this will increase to in excess of 200,000 people in the coming years. Since its inception, Diabetic RetinaScreen has provided over half a million eye screening tests. The programme has referred approx. 47,000 participants to hospital for follow up or treatment.
To support the delivery of the Diabetic RetinaScreen programme, the HSE wishes to notify the market of its intention to procure a suitably qualified photographic and grading service to deliver retina screening. This is not a call for competition. A Contract Notice will issue in due course to commence the procurement process.
II.3)
Estimated date of publication of contract notice:
15/06/2022
Section IV: Procedure
IV.1)
Description
IV.1.8)
Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement
: yes
IV.2)